Tuesday, October 27, 2020
wellness India Expo
Home Tags USFDA

Tag: USFDA

Metropolis Healthcare & NACO come together under PPP for HIV Viral...

Through this game-changing initiative by the government, NACO and Metropolis will together impact lives of lakhs of patients. All tests to be conducted at the Metropolis Global Reference Laboratory located in Kurla, Mumbai and other Metropolis Labs............

Sanat’s manufacturing unit in Sikandrabad undergoes successful USFDA inspection

The USFDA team thoroughly reviewed Sanat products’s herbal extract manufacturing, quality control, and quality assurance procedures during an inspection that was carried out during December 2017.............

USFDA approves Mylan & Biocon´s biosimilar for breast, gastric cancers

Mylan anticipates potentially being the first company to provide patient access to a biosimilar to Herceptin, representing a significant milestone for Mylan, Biocon and the overall healthcare system........

Post USFDA nod, Panacea Biotec set to launch Prasugrel tablets in...

The New Delhi based Panacea Biotec has received final approval from the US Food and Drug Administration to launch generic Prasugrel tablets in the American market..........

Biocon confident of resolving issues with USFDA over biosimilar ‘pegfilgrastim’

While the company is set to launch proposed biosimilar, Pegfilgrastim in the United States market, the US Food and Drug Administration has issued Complete Response Letter (CRL) to it seeking more data on the cancer drug..............

Public hospitals keeping Indian medical devices out of bounds for patients?

The association of domestic MedTech players, AIMED has issued a list of tenders recently floated by over 20 public institutions including state medical corporations, and hospitals which have stipulated discriminatory restrictive clauses...............

Pharma recalls posing a serious threat?

There have been several other instances wherein drugs are being recalled either on a firm's own initiative or the request by Food and Drug Administration (FDA)............

Panacea Biotec announces joint collaboration with Biopharma Inc

Under the collaboration, Panacea Biotec will be responsible for manufacturing and supply of the new drug entities of Biopharma Inc which again will be a distributor of these ANDAs in the United States and its territories..........

Biocon & Mylan’s proposed biosimilar ‘Trastuzumab’ gets USFDA nod

The US-FDA Oncologic Drugs Advisory Committee has unanimously recommended approval of Mylan and Biocon’s proposed cancer targeting biosimilar, Trastuzumab.............

Dr Reddy’s Laboratories gets USFDA’s EIR to API plant in Telangana

The US Food and Drug Administration has given an 'establishment inspection report' to the company after inspection of Dr Reddy Laboratories active pharmaceutical ingredients (API) unit at Miryalaguda in Telangana.........